VOV.VN - As a responsible member state of the international community the nation is ready to co-operate with other countries in the fight against the novel coronavirus (COVID-19).
VOV.VN - At present Vietnam has successfully produced two novel coronavirus (COVID-19) vaccines, namely Nanocovax and Covivac.
Southeast Asia’s economic growth will rebound to 6.2 % in 2021 with Vietnam achieving 8 % growth, according to the latest economic outlook report from Oxford Economics commissioned by chartered accountancy body ICAEW.
All Vietnamese people who joined a survey in December last year said that they fully support and give the Vietnamese Government approval on how it had worked to control the pandemic, according the Bangkok-based ScandAsia magazine.
VOV.VN - A group of three volunteers are set to receive the first shot of a 75mcg dose of the Nanocovax vaccine on January 18, the highest quantity of the vaccine which will be trialed on participants.
Credit growth in Vietnam may reach 13-14% this year, partly driven by progress with the COVID-19 vaccine, according to a 2021 banking outlook report released by the SSI Securities Corporation on January 6.
VOV.VN - Vietnam has reached a deal with the United Kingdom’s AstraZeneca to purchase 30 million doses of its COVID-19 vaccine for local use, said Deputy Minister of Health Truong Quoc Cuong.
VOV.VN -The Ministry of Health has granted permission to the Nha Trang-based Institute of Vaccines and Biological Medical (IVAC) to carry out human clinical tests for Covivac, a locally-produced novel coronavirus (COVID-19) vaccine, on volunteers in January, two months ahead of schedule.
VOV.VN - Vietnam is ready to join the international community in preventing and combating epidemics, including the current novel coronavirus pandemic, to build a better future for all, said Prime Minister Nguyen Xuan Phuc.
VOV.VN - Three local volunteers were given a 50mcg dose of the Made-in-Vietnam novel coronavirus (COVID-19) vaccine Nano Covax on December 26 at the Hanoi-based Military Medical Academy.